Jennerex and Lee’s Pharmaceuticals Announce Partnership for JX-594 in China

Jennerex Inc., a clinical-stage biotherapeutics company developing a proprietary breakthrough class of targeted oncolytic virus therapeutics, today announced in conjunction with Lee’s Pharmaceutical Holdings, the execution of a collaboration and license agreement for Jennerex’s lead product candidate, JX-594 (liver cancer treatment), in certain Asian territories. Lee’s is a fully integrated pharmaceutical group with operations in People’s Republic of China (PRC), Hong Kong and Macau.

Read more on Jennerex new >

About Ottawa Technology Transfer Network
The Ottawa Technology Transfer Network (OTTN) is a collaboration among academic research institutions affiliated with the University of Ottawa and who's goal is to enhance the economic impact of research commercialization through the sharing of best practices, enhanced market knowledge, student engagement and proactive industrial interation. OTTN members include the University of Ottawa, the Ottawa Hospital Research Institutie (OHRI), the Childrens' Hospital of Eastern Ontario (CHEO) and the Unviversity of Ottawa Heart Institute (UOHI)

Comments are closed.

%d bloggers like this: